Q3989474 (Q3989474): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item: importing one item from Netherlands) |
||||||||||||||
| Property / instance of | |||||||||||||||
| Property / instance of: Kohesio project / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / financed by | |||||||||||||||
| Property / financed by: European Union / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / country | |||||||||||||||
| Property / country: Kingdom of the Netherlands / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / start time | |||||||||||||||
1 January 2019
| |||||||||||||||
| Property / start time: 1 January 2019 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / start time | |||||||||||||||
31 December 2021
| |||||||||||||||
| Property / start time: 31 December 2021 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
Caelus Pharmaceuticals B.V. | |||||||||||||||
| Property / beneficiary name (string): Caelus Pharmaceuticals B.V. / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary | |||||||||||||||
| Property / beneficiary: Q3987337 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
78,331.0 Euro
| |||||||||||||||
| Property / EU contribution: 78,331.0 Euro / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
391,654.0 Euro
| |||||||||||||||
| Property / budget: 391,654.0 Euro / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / co-financing rate | |||||||||||||||
20.0 percent
| |||||||||||||||
| Property / co-financing rate: 20.0 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / fund | |||||||||||||||
| Property / fund: European Regional Development Fund / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / postal code | |||||||||||||||
1105 BP | |||||||||||||||
| Property / postal code: 1105 BP / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / programme | |||||||||||||||
| Property / programme: West Netherlands - ERDF / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / intervention field | |||||||||||||||
| Property / intervention field: Technology transfer and university-enterprise cooperation primarily benefiting SMEs / rank | |||||||||||||||
Normal rank | |||||||||||||||
Revision as of 16:30, 13 December 2021
Project Q3989474 in Netherlands
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3989474 in Netherlands |
Statements
78,331.0 Euro
0 references
391,654.0 Euro
0 references
20.0 percent
0 references
1 January 2019
0 references
31 December 2021
0 references
Caelus Pharmaceuticals B.V.
0 references
1105 BP
0 references
Identifiers
OP-2014-2023-West-KVW-00211
0 references